Orthofix Medical Inc.

Orthofix Medical Inc.

NNASDAQ:OFIX
6.80
USD
-0.37
(-5.16%)
-1.11EPS
383.45MMarket Cap
Feb 19Next Earn

Total Valuation

USD

As of September 30, 2026, Orthofix Medical Inc. carries a market capitalization of 383.45M, placing it among publicly traded companies globally. Its enterprise value stands at 559.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap383.45M
Enterprise Value559.21M

Important Dates

Orthofix Medical Inc.'s next confirmed earnings release is scheduled for February 19, 2027.

Earnings Date2/19/2027

Share Statistics

As of September 30, 2026, Orthofix Medical Inc. has 40.75M shares outstanding.

Shares Outstanding40.75M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.46, and the price-to-book ratio stands at 0.89.

PS Ratio0.46
PB Ratio0.89
P/TBV Ratio2.23
P/FCF Ratio90.46
P/OCF Ratio90.46

Enterprise Valuation

As of September 30, 2026, Orthofix Medical Inc. trades at an EV/EBITDA multiple of 14.80 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.67 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 559.21M versus a market cap of 383.45M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.67
EV / EBITDA14.80

Financial Position

As of September 30, 2026, Orthofix Medical Inc. maintains a current ratio of 3.11, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 61.01, indicating elevated leverage, while an interest coverage ratio of 2.35 demonstrates limited ability to service its debt obligations.

Current Ratio3.11
Quick Ratio1.58
Debt / Equity61.01
Debt / EBITDA6.93
Interest Coverage2.35

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Orthofix Medical Inc. posted a negative return on equity (ROE) of -10.32, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.33, reflecting losses generated across the asset base. The company generates approximately 520,507.17 in revenue per employee across its workforce of 1,605.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.34 indicates how many times Orthofix Medical Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-10.32
Return on Assets (ROA)-5.33
Revenue Per Employee520,507.17
Employee Count1,605.00
Inventory Turnover1.34

Taxes

USD

Over the twelve months ended September 30, 2026, Orthofix Medical Inc. recorded 1.73M in income tax expense. The company reported a pretax loss of -43.27M and -45.00M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax1.73M

Stock Price Statistics

USD

As of the close on November 16, 2026, Orthofix Medical Inc.'s stock has declined approximately 54.52% over the past 52 weeks. The 50-day moving average sits at 9.02, while the 200-day moving average is 10.79.

52-Week Price Change-54.52%
50-Day Moving Average9.02
200-Day Moving Average10.79

Income Statement

USD

Over the twelve months ended September 30, 2026, Orthofix Medical Inc. generated 835.41M in revenue and converted that into -45.00M in net income, yielding earnings per share of -1.11. EBITDA reached 37.79M, while operating income came in at -16.86M.

Revenue835.41M
Gross Profit592.14M
Operating Income-16.86M
Pretax Income-43.27M
Net Income-45.00M
EBITDA37.79M
EBIT-20.53M
Earnings Per Share (EPS)-1.11

Balance Sheet

USD

As of September 30, 2026, Orthofix Medical Inc. holds 86.32M in cash and equivalents against 262.09M in total debt, resulting in a net debt position of 135.53M. Total book value stands at 429.57M, with working capital of 292.40M providing operational flexibility.

Cash & Cash Equivalents86.32M
Total Debt262.09M
Net Debt135.53M
Equity (Book Value)429.57M
Book Value Per Share10.54
Working Capital292.40M

Cash Flow

USD

Orthofix Medical Inc. produced 4.23M in operating cash flow over the twelve months ended September 30, 2026.

Operating Cash Flow4.23M
Free Cash Flow4.23M
FCF Per Share0.10

Margins

Over the twelve months ended September 30, 2026, Orthofix Medical Inc. posted a gross margin of 70.88, reflecting its pricing power and cost economics. The operating margin of -2.02 and net profit margin of -5.39 provide insight into operational efficiency.

Gross Margin70.88
Operating Margin-2.02
Pretax Margin-5.18
Profit Margin-5.39
EBITDA Margin4.52

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 1.11, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -17.11, meaning Orthofix Medical Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-17.11
FCF Yield1.11

Scores

As of September 30, 2026, Orthofix Medical Inc. has an Altman Z-Score of 1.47, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.47